The cardiolipin transacylase, tafazzin, associates with two distinct respiratory components providing insight into Barth syndrome.
Mutations in the mitochondrial cardiolipin (CL) transacylase, tafazzin (Taz1p), result in the X-linked cardioskeletal myopathy, Barth syndrome (BTHS). The mitochondria of BTHS patients exhibit variable respiratory defects and abnormal cristae ultrastructure. The biochemical basis for these observations is unknown. In the absence of its target phospholipid, CL, a very large Taz1p complex is missing, whereas several discrete smaller complexes are still observed. None of the identified Taz1p complexes represents Taz1p homodimers. Instead, yeast Taz1p physically assembles in several protein complexes of distinct size and composition. The ATP synthase and AAC2, both required for oxidative phosphorylation, are identified in separate stable Taz1p complexes. In the absence of CL, each interaction is still detected albeit in reduced abundance compared with when CL is present. Taz1p is not necessary for the normal expression of AAC2 or ATP synthase subunits or assembly of their respective complexes. In contrast, the largest Taz1p complex requires assembled ATP synthase and CL. Mitochondria in Delta taz1 yeast, similar to ATP synthase oligomer mutants, exhibit altered cristae morphology even though ATP synthase oligomer formation is unaffected. Thus, the Taz1p interactome defined here provides novel insight into the variable respiratory defects and morphological abnormalities observed in mitochondria of BTHS patients.
Claypool
Steven M
SM
Department of Chemistry and Biochemistry, David Geffen School of Medicine, University of California, Los Angeles, CA 90095-1569, USA.
Boontheung
Pinmanee
P
McCaffery
J Michael
JM
Loo
Joseph A
JA
Koehler
Carla M
CM
D000217:Acyltransferases / Q000235:genetics / Q000378:metabolism*; D002308:Cardiolipins / Q000378:metabolism; D019069:Cell Respiration / Q000502:physiology*; D019281:Dimerization; D006801:Humans; D008928:Mitochondria / Q000378:metabolism / Q000473:pathology / Q000648:ultrastructure; D000226:Mitochondrial ADP, ATP Translocases / Q000737:chemistry / Q000235:genetics / Q000378:metabolism; D028361:Mitochondrial Diseases / Q000378:metabolism*; D025261:Mitochondrial Proton-Translocating ATPases / Q000737:chemistry / Q000235:genetics / Q000378:metabolism; D010743:Phospholipids / Q000737:chemistry / Q000378:metabolism; D011487:Protein Conformation; D025941:Protein Interaction Mapping; D013577:Syndrome; D014157:Transcription Factors / Q000737:chemistry / Q000235:genetics / Q000378:metabolism*
D002308:Cardiolipins; D010743:Phospholipids; D014157:Transcription Factors; D000226:Mitochondrial ADP, ATP Translocases; D000217:Acyltransferases; C108675:TAFAZZIN protein, human; D025261:Mitochondrial Proton-Translocating ATPases
Yeast. 1994 Dec;10(13):1793-808
7747518
J Biol Chem. 2008 Apr 11;283(15):9749-58
18252710
J Neurol Sci. 1983 Dec;62(1-3):327-55
6142097
Biochem J. 2005 May 1;387(Pt 3):617-26
15588229
Gene. 1989 Apr 15;77(1):51-9
2744487
FEBS Lett. 2005 Nov 7;579(27):6031-6
16226253
J Biol Chem. 2006 Dec 22;281(51):39217-24
17082194
Prog Lipid Res. 2000 May;39(3):257-88
10799718
Biochem Biophys Res Commun. 2000 Dec 20;279(2):378-82
11118295
FEBS Lett. 2006 Oct 9;580(23):5450-5
16973164
Mol Cell Biol. 1985 Dec;5(12):3610-6
3915782
J Biol Chem. 2005 Aug 19;280(33):29403-8
15972817
Biochem J. 2003 May 1;371(Pt 3):799-809
12534348
J Proteome Res. 2006 Jul;5(7):1543-54
16823961
J Biol Chem. 2003 Dec 26;278(52):52873-80
14561769
Proc Natl Acad Sci U S A. 2006 Aug 1;103(31):11584-8
16855048
Biochem Biophys Res Commun. 2003 Jan 3;300(1):65-74
12480522
Am J Med Genet. 1994 Apr 15;50(3):255-64
8042670
J Biol Chem. 1990 Nov 5;265(31):18797-802
2172233
J Cell Biol. 2008 Sep 8;182(5):937-50
18779372
Mol Microbiol. 2004 Jan;51(1):149-58
14651618
Circ Res. 2006 Jul 21;99(2):201-8
16794186
Biochemistry. 1985 Jul 16;24(15):3821-6
2996583
J Mol Biol. 2006 Aug 18;361(3):462-9
16857210
Lab Invest. 2007 Jan;87(1):40-8
17043667
Biochim Biophys Acta. 1988 Dec 22;946(2):227-34
3061466
Mol Biol Cell. 2005 Nov;16(11):5202-14
16135531
Mol Microbiol. 2008 May;68(4):1061-72
18430085
J Biol Chem. 2003 Oct 31;278(44):43089-94
12930833
J Am Coll Cardiol. 2003 Dec 3;42(11):1994-9
14662265
Am J Med Genet A. 2004 May 1;126A(4):349-54
15098233
J Lipid Res. 2005 Jun;46(6):1182-95
15805542
J Inherit Metab Dis. 1999 Jun;22(4):555-67
10407787
J Biol Chem. 1998 Feb 27;273(9):4872-7
9478928
J Biol Chem. 1994 Jan 21;269(3):1940-4
8294444
Clin Chem. 2002 Sep;48(9):1390-7
12194913
Mol Biol Cell. 1996 Jun;7(6):985-99
8817003
FEBS Lett. 2002 Sep 25;528(1-3):35-9
12297275
J Cell Biol. 2006 Jul 31;174(3):379-90
16880272
J Cell Biol. 2006 Oct 23;175(2):201-7
17043140
J Biol Chem. 1990 Nov 15;265(32):19434-40
2147180
Am J Med Genet. 1993 Feb 1;45(3):327-34
8434619
J Inherit Metab Dis. 1996;19(2):157-60
8739954
J Biol Chem. 1991 Jun 5;266(16):10047-9
2037561
J Biol Chem. 2000 Jul 21;275(29):22387-94
10777514
Cell. 2005 Nov 4;123(3):375-82
16269330
EMBO J. 2002 Feb 1;21(3):221-30
11823415
J Biol Chem. 1993 Jan 5;268(1):74-9
8380172
Biochemistry. 1999 Nov 9;38(45):14966-72
10555978
J Biol Chem. 2002 Nov 15;277(46):43553-6
12364341
Chem Phys Lipids. 2005 Dec;138(1-2):38-49
16226238
Biophys J. 1999 Oct;77(4):2003-14
10512820
EMBO J. 2008 Apr 9;27(7):1154-60
18323778